Clive Stanway
Clive trained as a scientist in cell and molecular biology at Imperial College and Oxford University, rising to junior faculty status.
Clive trained as a scientist in cell and molecular biology at Imperial College and Oxford University, rising to junior faculty status.
Andrew is a Director at venture capital firm, Midven. As Fund Principal of the UK Innovation & Science Seed Fund and the Early Advantage Fund, Andrew led two rounds of investment into Atelerix
Steve is a co-founder of Atelerix and Senior Applications Scientist for the company, with a deep interest in the development of new technologies for biomedical applications.
Che is the scientific founder and CSO at Atelerix, and is passionate about cell biology and regenerative medicine.
Sanj is a highly accomplished life science executive and renowed sales and marketing leader, with extensive international experience.
Mick is a chemist by training, a biologist by inclination and a business leader by experience.